FindTrial
Sign In

Comparative analysis in implant-supported metal ceramic and hibrid ceramic crown

Comparative analysis of Clinical and Molecular parameters in implant-supported Metal Ceramic and Hybrid Ceramic crowns

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9w9m83
Enrollment
Unknown
Registered
2018-06-05
Start date
2017-04-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth Loss

Interventions

Control group: 20 patients will receive implant-supported metal ceramic crowns. Test group: 20 patients will receive implant-supported ceramic hybrid. The crowns will be compared by clinical and radio
Procedure/surgery
E07.695

Sponsors

Faculdade de Odontologia de Bauru
Lead Sponsor
Faculdade de Odontologia de Bauru
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Edentulous sites for replacement of unitary prostheses in the premolar or molar regions; bone height at least 8.5 mm; minimum cervical bone thickness of 5 mm; minimum age of 18 years; ASA I or ASA II patients; periodontally healthy adjacent teeth without previous treatment of chronic / aggressive periodontal disease and without the need for prosthetic restoration; healthy natural antagonist teeth (absence of restorations or prostheses) and periodontally healthy.

Exclusion criteria

Exclusion criteria: History of alcoholism; smokers; illicit drug users; cardiopathy; decompensated diabetics; complex rehabilitation needs (alteration of vertical dimension of occlusion, need for other rehabilitation procedures); lack of height and sufficient bone thickness; patients with parafunctional habits (bruxism); grafted areas; irradiated patients; patients who underwent long-term steroid therapy or bisphosphonate users; periodontally compromised patients.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be comparison of two restorative materials by analyzing the inflammatory markers, because there are values of these markers that represent health or disease of peri-implant tissue in the scientific literature . Success or failure will be determined by establishment of the disease or not, and the markers values present in the peri-implant fluid will be correlated with the clinical parameters assessed in the study.The evaluation periods will be: 3, 5, 9, 15, 30, 90, 180 and 360 days after implant placement.—

Secondary

MeasureTime frame
Secondary outcomes are not expected.—

Countries

Brazil

Contacts

Public ContactCamila Moreira Machado

Faculdade de Odontologia de Bauru

machado.camilam@gmail.com+55 14 991134185

Outcome results

None listed

Source: REBEC (via WHO ICTRP)